Skip to main
CDNA

CareDx (CDNA) Stock Forecast & Price Target

CareDx (CDNA) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

CareDx is continuously expanding and diversifying their business, with recent acquisitions and an upcoming product launch. Their focus on the rapidly growing liquid biopsy and oncology diagnostics market, as well as their successful performance in the transplant industry, bodes well for the company's future growth. Additionally, their ambitious financial targets and successful RCM initiatives demonstrate a strong and strategic approach to driving profitability.

Bears say

CareDx is facing stiff competition and will need to generate sufficient revenue from its testing services in order to meet its growth expectations. However, the company expresses confidence in its commercial payer coverage and operational improvements, which may lead to an increase in ASPs and revenue. Despite these efforts, risks such as potential changes in technology and the need for inorganic growth opportunities may also impact the company's stock price.

CareDx (CDNA) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareDx and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareDx (CDNA) Forecast

Analysts have given CareDx (CDNA) a Buy based on their latest research and market trends.

According to 3 analysts, CareDx (CDNA) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareDx (CDNA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.